Viewing Study NCT04998669


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-31 @ 3:08 PM
Study NCT ID: NCT04998669
Status: RECRUITING
Last Update Posted: 2025-07-24
First Post: 2021-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor: Juan P. Alderuccio, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module